Puerarin Induces Ferroptosis in Colorectal Cancer Cells via Triggering NCOA4 Upregulation

Nutr Cancer. 2023;75(7):1571-1578. doi: 10.1080/01635581.2023.2216922. Epub 2023 Jun 1.

Abstract

Puerarin shows promise as an anti-cancer compound, but its mechanism of action remains unclear. Here we explored whether and how it promotes ferroptosis in a colorectal cancer cell line. The level of ferroptosis and expression of autophagy proteins were compared between puerarin-treated HT-29 cells expressing normal or reduced levels of the autophagy protein ATG5 or the ferritinophagy protein nuclear receptor coactivator 4 (NCOA4). Puerarin increased lipid peroxidation and inhibited cell proliferation in a dose-dependent manner, indicating the induction of ferroptosis. These effects were partially reversed by ferrostatin-1, a scavenger of reactive oxygen species; by the iron chelator deferiprone; by repression of autophagy through administration of 3-methyladenine or knockdown of autophagy-related gene 5 (ATG5); or by repression of ferritinophagy through NCOA4 knockdown. Puerarin may induce the proliferative inhibition of colorectal cancer cells by triggering ferroptosis through a mechanism requiring NCOA4 ferritinophagy.

MeSH terms

  • Autophagy
  • Colorectal Neoplasms* / drug therapy
  • Ferroptosis*
  • Humans
  • Iron / metabolism
  • Nuclear Receptor Coactivators / genetics
  • Nuclear Receptor Coactivators / metabolism
  • Transcription Factors / genetics
  • Up-Regulation

Substances

  • puerarin
  • Iron
  • Transcription Factors
  • NCOA4 protein, human
  • Nuclear Receptor Coactivators